Difference between revisions of "Apocrine metaplasia of the breast"
Jump to navigation
Jump to search
| Line 8: | Line 8: | ||
===Etiology=== | ===Etiology=== | ||
*Increased number of mitochondria. | *Increased number of mitochondria. | ||
**In other body sites this has different names, e.g. '' | **In other body sites this has different names, e.g. ''Hurthle cell change'' (thyroid), ''[[oncocytoma|oncocytic]] change'' (kidney). | ||
==Microscopic== | ==Microscopic== | ||
Revision as of 18:35, 10 March 2016
Apocrine metaplasia of the breast, also apocrine metaplasia, is a benign change in the breast without increased risk of malignancy.
General
- Benign/not significant. Can be considered to be pretty wallpaper in the house of breast pathology.
- Very common in adults.
- Apocrine lesions as a group are usually benign, some pre-neoplastic and some malignant.[1]
Etiology
- Increased number of mitochondria.
- In other body sites this has different names, e.g. Hurthle cell change (thyroid), oncocytic change (kidney).
Microscopic
Features:
- Eosinophilic cytoplasm - key feature.
- Voluminous pink cytoplasm.
- Apocrine snouts may be present.
- Small protrusiona at the apical aspect of the cell (composed of cytoplasm and plasma membrane).
- Central round nucleus
- Prominent nuclear membrane.
- Prominent, often single nucleolus.
Note:
- Apocrine changes, i.e. cytoplasmic eosinophilia, can appear in malignant tumours; eosinophilia doesn't make something benign.
Images
FCC with apocrine metaplasia (right bottom of image) - high mag. (WC/Nephron).
Breast - Apocrine Change - high power (SKB)
Sign out
- Typically not reported.
See also
References
- ↑ Wells, CA.; El-Ayat, GA. (Dec 2007). "Non-operative breast pathology: apocrine lesions.". J Clin Pathol 60 (12): 1313-20. doi:10.1136/jcp.2006.040626. PMID 18042688.